Marc Tessier-Lavigne, PhD
Marc Tessier-Lavigne is President of The Rockefeller University, where he also heads the Laboratory of Brain Development and Repair. Dr. Tessier-Lavigne and colleagues pioneered the identification of mechanisms that direct the formation of connections among nerve cells in the embryonic brain and spinal cord, and have been applying these insights to neural repair following spinal cord injury and to neurodegenerative diseases like Alzheimer’s.
A Rhodes scholar, member of the US National Academy of Sciences, and Fellow of the Royal Society (UK) and the Royal Society of Canada, Dr. Tessier-Lavigne obtained undergraduate degrees from McGill and Oxford universities and a Ph.D. from University College London (UCL), performed postdoctoral work at UCL and at Columbia University, and held faculty positions at the University of California, San Francisco, and at Stanford University, where he was the Susan B. Ford Professor in the Humanities and Sciences and an investigator with the Howard Hughes Medical Institute.
In 2003, he joined Genentech, a leading biotechnology company, where he assumed positions of increasing responsibility and was promoted to Executive Vice President, Research, and Chief Scientific Officer. As head of the Genentech Research organization, he directed 1,400 scientists in disease research and drug discovery for cancer, immune disorders, infectious diseases, and neurodegenerative diseases. He moved to Rockefeller in March 2011.